These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24577468)

  • 1. Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging.
    de Cristóbal J; García-García L; Delgado M; Pérez M; Pozo MA; Medina M
    J Alzheimers Dis; 2014; 40 Suppl 1():S79-89. PubMed ID: 24577468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
    Matsumoto G; Matsumoto K; Kimura T; Suhara T; Higuchi M; Sahara N; Mori N
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A seeding based cellular assay of tauopathy.
    Xu Y; Martini-Stoica H; Zheng H
    Mol Neurodegener; 2016 Apr; 11():32. PubMed ID: 27112488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
    Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
    Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
    Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy.
    Zimova I; Brezovakova V; Hromadka T; Weisova P; Cubinkova V; Valachova B; Filipcik P; Jadhav S; Smolek T; Novak M; Zilka N
    J Alzheimers Dis; 2016 Sep; 54(2):831-43. PubMed ID: 27567836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling tauopathy: a range of complementary approaches.
    Hall GF; Yao J
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):224-39. PubMed ID: 15615641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model to study tau pathology related with tau phosphorylation and assembly.
    Engel T; Lucas JJ; Hernández F; Avila J
    J Neurol Sci; 2007 Jun; 257(1-2):250-4. PubMed ID: 17362999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
    Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
    J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.
    Kambe T; Motoi Y; Inoue R; Kojima N; Tada N; Kimura T; Sahara N; Yamashita S; Mizoroki T; Takashima A; Shimada K; Ishiguro K; Mizuma H; Onoe H; Mizuno Y; Hattori N
    Neurobiol Dis; 2011 Jun; 42(3):404-14. PubMed ID: 21324362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model.
    Cook C; Kang SS; Carlomagno Y; Lin WL; Yue M; Kurti A; Shinohara M; Jansen-West K; Perkerson E; Castanedes-Casey M; Rousseau L; Phillips V; Bu G; Dickson DW; Petrucelli L; Fryer JD
    Hum Mol Genet; 2015 Nov; 24(21):6198-212. PubMed ID: 26276810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model.
    Marinković P; Blumenstock S; Goltstein PM; Korzhova V; Peters F; Knebl A; Herms J
    Brain; 2019 Apr; 142(4):1051-1062. PubMed ID: 30847469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
    Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
    J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau oligomers as potential targets for early diagnosis of tauopathy.
    Sahara N; Ren Y; Ward S; Binder LI; Suhara T; Higuchi M
    J Alzheimers Dis; 2014; 40 Suppl 1():S91-6. PubMed ID: 24595194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of
    Weng CC; Hsiao IT; Yang QF; Yao CH; Tai CY; Wu MF; Yen TC; Jang MK; Lin KJ
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
    Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
    Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of tau hyperphosphorylation and neurotransmitter markers in the brainstem of senescent tau filament forming transgenic mice.
    Morcinek K; Köhler C; Götz J; Schröder H
    Brain Res; 2013 Feb; 1497():73-84. PubMed ID: 23261664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinase activities increase during the development of tauopathy in htau mice.
    Kelleher I; Garwood C; Hanger DP; Anderton BH; Noble W
    J Neurochem; 2007 Dec; 103(6):2256-67. PubMed ID: 17908241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.